Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (171-180 of 285) with videos related to

Pageof 29
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 6, 2026
Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative reviewPieter Maerten, Albert Wolthuis, André D'Hoore, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
European Urology|May 29, 2012
Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysisAlberto Briganti, Thomas Wiegel, Steven Joniau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Inflammation-Based Index and <sup>68</sup>Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with <sup>90</sup>Y-DOTATOCElin Pauwels, Sofie Van Binnebeek, Vincent Vandecaveye, et al.
Clinical and Translational Radiation Oncology|August 22, 2022
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort studyPhilippe P Bulens, Lien Smets, Annelies Debucquoy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2022
Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysisTiuri E Kroese, Hanneke W M van Laarhoven, Magnus Nilsson, et al.
Cancer Treatment Reviews|June 18, 2013
What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?Roel C J Schlijper, Janneke P C Grutters, Ruud Houben, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancerAnnelies Debucquoy, Karin Haustermans, Anneleen Daemen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2014
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapySofie Van Binnebeek, Kristof Baete, Bert Vanbilloen, et al.
Pageof 29

Showing results (171-180 of 285) with videos related to

Sort By:
Pageof 29
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 6, 2026
Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative reviewPieter Maerten, Albert Wolthuis, André D'Hoore, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
European Urology|May 29, 2012
Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysisAlberto Briganti, Thomas Wiegel, Steven Joniau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Inflammation-Based Index and <sup>68</sup>Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with <sup>90</sup>Y-DOTATOCElin Pauwels, Sofie Van Binnebeek, Vincent Vandecaveye, et al.
Clinical and Translational Radiation Oncology|August 22, 2022
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort studyPhilippe P Bulens, Lien Smets, Annelies Debucquoy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2022
Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysisTiuri E Kroese, Hanneke W M van Laarhoven, Magnus Nilsson, et al.
Cancer Treatment Reviews|June 18, 2013
What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?Roel C J Schlijper, Janneke P C Grutters, Ruud Houben, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancerAnnelies Debucquoy, Karin Haustermans, Anneleen Daemen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2014
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapySofie Van Binnebeek, Kristof Baete, Bert Vanbilloen, et al.
Pageof 29